Mirmosayyeb Omid, Barzegar Mahdi, Nehzat Nasim, Najdaghi Soroush, Ansari Behnaz, Shaygannejad Vahid
Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Curr J Neurol. 2020 Apr 3;19(2):59-66. doi: 10.18502/cjn.v19i2.4942.
Multiple sclerosis (MS) is a common autoimmune inflammatory disease in the central nervous system (CNS) without exact pathology. Environmental factors such as infections have a causal or protective role in MS. Helicobacter pylori (HP) is one of the infections in digestive diseases and previous studies reported controversial findings of this infection role in MS. So, we conducted this study to assess the frequency of HP infection in patients with MS in comparison to the healthy population. This cross-sectional study was undertaken between 2015 and 2019. 191 participants including 58 patients with clinically isolated syndrome (CIS), 57 patients with relapsing-remitting MS (RRMS), 39 patients with secondary progressive MS (SPMS), and 39 age- and sex-matched healthy controls (HCs) were tested for the presence of HP immunoglobulin G (IgG) and IgM antibodies (Abs) in their serum sample. The frequency of HP IgG seropositivity in patients with SPMS was significantly higher than patients with CIS [Odds ratio (OR): 6.333, 95% confidence interval (CI): 2.522-15.906, P < 0.001], patients with RRMS (OR: 4.583, 95% CI: 1.842-11.407, P = 0.001), and HCs (OR: 8.485, 95% CI: 3.058-23.540, P < 0.001). We did not find a significant difference among other study groups regarding IgG seropositivity. No significant difference among groups regarding HP IgM seropositivity was evident. On univariate model, Expanded Disability Status Scale (EDSS) score (OR: 1.038, 95% CI: 1.038-1.460, P = 0.017) and SPMS (OR: 4.583, 95% CI: 1.842-11.407, P = 0.001) were predictor for HP IgG seropositivity. On multivariate model, only SPMS had higher risk for HP IgG seropositivity compared to RRMS (OR: 5.554, 95% CI: 1.327-23.253, P = 0.019). We did not find a significant association between clinical and demographic variables with HP IgM seropositivity. Based on our findings, progressive MS and HP infection may have association. Further longitudinal studies with large sample size are needed to determine the role of HP infection in MS.
多发性硬化症(MS)是中枢神经系统(CNS)常见的自身免疫性炎症疾病,其病理尚不明确。感染等环境因素在MS中具有致病或保护作用。幽门螺杆菌(HP)是消化系统疾病中的感染源之一,既往研究报道了该感染在MS中作用的矛盾结果。因此,我们开展本研究以评估MS患者与健康人群相比HP感染的频率。本横断面研究于2015年至2019年进行。对191名参与者进行检测,包括58例临床孤立综合征(CIS)患者、57例复发缓解型MS(RRMS)患者、39例继发进展型MS(SPMS)患者以及39名年龄和性别匹配的健康对照(HCs),检测其血清样本中HP免疫球蛋白G(IgG)和免疫球蛋白M(IgM)抗体(Abs)的存在情况。SPMS患者中HP IgG血清阳性率显著高于CIS患者[比值比(OR):6.333,95%置信区间(CI):2.522 - 15.906,P < 0.001]、RRMS患者(OR:4.583,95% CI:1.842 - 11.407,P = 0.001)以及HCs(OR:8.485,95% CI:3.058 - 23.540,P < 0.001)。我们未发现其他研究组在IgG血清阳性率方面存在显著差异。各研究组在HP IgM血清阳性率方面无明显差异。在单变量模型中,扩展残疾状态量表(EDSS)评分(OR:1.038,95% CI:1.038 - 1.460,P = 0.017)和SPMS(OR:4.583,95% CI:1.842 - 11.407,P = 0.001)是HP IgG血清阳性的预测因素。在多变量模型中,与RRMS相比,只有SPMS发生HP IgG血清阳性的风险更高(OR:5.554,95% CI:1.327 - 23.253,P = 0.019)。我们未发现临床和人口统计学变量与HP IgM血清阳性之间存在显著关联。基于我们的研究结果,进展型MS与HP感染可能存在关联。需要进一步开展大样本量的纵向研究以确定HP感染在MS中的作用。